Adult polycystic kidney disease (APKD) is an autosomal dominant disorder, displaying variable age at diagnosis and severity.' 2 The incidence is around 1 in 1000 births3 with a mutation rate of 6-5 to 12 x 10-5.4 It is a common and often potentially fatal multisystem disorder, the major abnormality being the progressive enlargement of cysts in several organs, primarily the kidney, resulting in chronic renal failure. It accounts for approximately 9-5% of the total dialysis and transplant workload of the renal units in South Wales, thus proving a substantial economic burden.5 6 The basic biochemical defect is as yet unknown,7 and current therapy is ineffective in the retardation of cyst development. In the past, gene carriers were discovered when they were symptomatic or had affected offspring. Recently, ultrasonographic scanning (USS) This report analyses South Wales APKD families with the 3'HVR marker and polymorphisms within the a globin locus, the study forming part of a broader genetic and population study of the disorder in the region.
Materials and methods
A total of 139 families was identified from the dialysis and transplant registers of the Cardiff Royal Infirmary Renal unit (serving a population of 2-1 x genetic linkage analysis, of whom 81 were affected and 67 were at risk of carrying the disease, the total including those whose DNA typing was inferred. Diagnosis of symptomatic cases was confirmed by USS. Asymptomatic at risk subjects were only included when aged over 20, after informed consent had been obtained. Diagnostic criteria were the finding of a minimum of two cysts in one kidney and one cyst in the other.' Only three subjects were found to be equivocal using USS, of whom one was rescreened independently from the study using computerised tomography (CT) and found to be affected; the other two were not included in the analysis.
DNA ANALYSIS
Blood samples were taken in EDTA tubes and frozen at -20°C. Total genomic DNA was prepared from the leucocytes of 20 ml of blood by a triton X-100 method. ' Restriction enzymes PvuII and RsaI (BRL Ltd, Cambridge) were used to digest DNA, under conditions recommended by the manufacturers, and fragments separated by size using a gel of 0-8% agarose-ultrapure (BRL Ltd, Cambridge). Southern blots were performed to transfer fragments onto a membrane (N-Hybond, Amersham). DNA was fixed to the membrane by UV irradiation for five minutes and baked for one hour at 800C.32P labelled probe 3'HVR was used for hybridisation. The probe was prepared from a 4 kb Hinfl restriction enzyme fragment, containing the entire 3'HVR, subcloned into a vector pSP641" 12 and from the a globin gene as a 1-3 kb fragment in PBR322 (TET Resistant, MRC Haematology Unit, Oxford). '3 Hybridisation was carried out for approximately 18 hours at 65°C, with 5 x 107 CPM/ml in N-Hybond recommended conditions. Filters were washed for one hour in 2 x SSC + 0-1O/% SDS at room temperature, in 0-1 x SSC + 0-I% SDS at 650C for one hour, and were exposed at -70°C to Fuji x ray film for one to five days. using an X-ograph intensifying screen. Allele inheritance was assessed directly.
Results
Figs 1 and 2 show the band patterns obtained using the a globin and the 3'HVR probes respectively. No cross overs were seen between the inheritance of alleles detected by these two markers6; the regions they recognise have therefore been considered one locus for analysis, allowing haplotypes to be used. The results show linkage between the a globin gene cluster and APKD locus, with three recombinants out of 83 phase known meioses and a maximum lod score of Z =24 187 at 0 =0-03 (based on a haplotype between a globin and the 3'HVR allele inheritance in 12 families).
Non-symptomatic at risk subjects with a prior risk of 50% that they carried the APKD gene had their risks altered as a function of their age at negative screening with USS' as follows: age 15 to 20 years 0-34; 20 to 30 years 0-14; 30+ years 0-05. These risks were used in the age of onset correction option of MLINK and LIPED.'4 '5 The LIPED programme was used for the calculation of linkage when segregating for sex, and MLINK for calculation of haplotypes. Subjects not at risk were governed by the disease frequency in the general population of in 1000.
The families studied were analysed with and without using the age of onset probability (tables 1 to 4). No significant difference in recombination fraction was observed, even when analysed separately for each sex (tables 5 to 8). Our results show only three recombinations, all of which were in male meioses. Subject 111.22 in APKD family 1 (1-111.22) and subject 11.1 in APKD family 12 .1) were found k. " .. to carry the affected haplotype, but on USS were observed to be normal, therefore appearing to be cross overs. It must be taken into account though that subject 1-111.22 was scanned using USS at the age of 20 and therefore still has a 14% risk of expressing the disease in later life. Subject 12-11.1 was aged 33 when scanned using USS and therefore only has a <5'%o risk.
ii.. variability of copy number of the element resulting in polymorphism. The probe hybridises to two allelic fragments in each subject, fragments varying in size from 1-8 kb to 8 kb and in all meioses tested, following Mendelian segregation. As the identity of electrophoretically indistinguishable alleles in a highly polymorphic system cannot be assumed, allele frequencies have to be estimated. Because of the great number of alleles being seen in a family using the 3'HVR (in APKD family 1, 22 were seen), analysis of the inheritance of the disease with a particular allele is complex. Alleles entering a pedigree from outside, that is, those alleles brought in by the unrelated spouses, were given a common designation to cut down on the number of alleles in a pedigree as far as possible, to aid the computer analysis of the results. TABLE 3 Individual family lod score, A PKD vs a globin, when at risk subjects were given a prior probability from their age. TABLE 4 Individual family lod score, APKD vs 3'HVR, when at risk subjects were given a prior probability from their age. 
